<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01608477</url>
  </required_header>
  <id_info>
    <org_study_id>BRIGHT</org_study_id>
    <nct_id>NCT01608477</nct_id>
  </id_info>
  <brief_title>Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation</brief_title>
  <acronym>BRIGHT</acronym>
  <official_title>Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Basel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KU Leuven, Belgium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Missouri, Kansas City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario À Coruña, Spain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliero, Universitaria Pisana</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>U.S. Department of Veterans Affairs, USA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>George Washington University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hopital Louis Pradel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpital Nord Laennec, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Groupe Hospitalier Pitie-Salpetriere</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Heidelberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Udine, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bologna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital de Sant Pau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Puerta de Hierro University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario La Fe</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario Reina Sofia de Cordoba</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Zürich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Papworth Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Freeman Hospital, UK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Brompton &amp; Harefield NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Toronto General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Ottawa Heart Institute, Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Paul's Hospital, Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>London Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke University Hospital, USA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cedars-Sinai Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kaiser Permanente Santa Clara Medical Center, USA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St Luke's Hospital, USA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital of the University of Pennsylvania, USA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ochsner Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Israelita Albert Einstein</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto Dante Pazzanese de Cardiologia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto do Coração da Universidade de São Paulo, Brazil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St Vincent's Hospital, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Prince Charles Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Astellas Pharma Europe Ltd., UK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Basel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Over the past decades, survival rates in heart transplantation recipients improved
      significantly, due to advancements in regimens of immunosuppressives and surgical techniques,
      but are still limited to the first 12 months post transplantation. Long-term survival remains
      almost unchanged indicating the need to identify and improve relevant factors. Evidence in
      other chronically-ill patient populations shows that the healthcare system (e.g. level of
      chronic illness management (CIM)) and patient self-management (e.g. adherence) drive
      improvements in outcomes.

      The BRIGHT study is the first multi-centre, multi-continental study examining healthcare
      system and heart transplant centres chronic illness management practice patterns and
      potential correlates of immunosuppressive medication nonadherence.

      The knowledge gained will inform clinicians, researchers and healthcare policy makers about
      the level(s) interventions need to be implemented at to improve long-term outcomes for
      transplant recipients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: After receiving a heart transplant (HTx) patients have to adhere to a number of
      health behaviors (e.g., medication taking, and smoking cessation) in order to guarantee
      optimal outcomes. Non-adherence to these health behaviors is associated with poor clinical
      and economic outcomes. However, the prevalence of non-adherence to these health behaviors is
      high among HTx recipients. Furthermore, differences in prevalences among countries and
      continents are observed. The extent to which a HTx recipient is adherent is affected by a
      variety of risk factors, namely 1) patient-related factors, 2) socioeconomic factors, 3)
      therapy-related factors, 4) health-related factors and 5) healthcare system and team factors.
      To-date, this last group of factors only received limited attention in understanding the
      complex phenomena of adherence.

      Aims: The aims of this study are:

        1. To describe CIM practice patterns among centres, countries/continents in HTx.

        2. To assess the prevalence and variability of nonadherence to treatment regimen, i.e.
           medication taking, smoking cessation, diet keeping, alcohol consumption, physical
           activity, sun protection and appointment keeping in HTx recipients among centres,
           countries/continents.

        3. To determine which multi-level factors are related to immunosuppressive medication
           adherence at the different system levels

        4. To benchmark the participating centres, countries and continents in relation to CIM
           practice patterns and non-adherence to health behaviours

      Methodology: The BRIGHT study is an international, multi-center, cross-sectional study. Data
      were collected using interviews and questionnaires. HTx recipients, nurses working in the
      post-transplantation care of HTx recipients and the medical directors of the HTx programs
      were surveyed. The investigators recruited a convenience sample of 36 heart transplantation
      centers (North America (n= 12), European (n= 19), Australia (n= 2) and South America (n= 3)).
      Within participating centers, a random sample of patients who met the study eligibility
      criteria was selected. Per center, a minimum of 20 and a maximum of 60 patients were
      included. In total, 1677 heart transplant recipients were invited to participate in this
      study. The questionnaires used in this study will be existing questionnaires (e.g. BAASIS
      interview to assess adherence with medications, DASS to assess depression) as well as
      questionnaires developed for this study.

      During a regular follow-up visit, patients were invited by a staff person to participate in
      this study. The staff first informed the patient about the study and, if the patient was
      willing to participate, retrieved a signed informed consent. Participating in this study was
      voluntary. Informed consent of the nurses and the medical director of the transplant center
      were implied by completing the questionnaires. Participant names will be held in strict
      confidence and will remain anonymous in research reports or publications.

      The results of the benchmarking of the parameters assessed in this study will be reported by
      figures and tables. Because of privacy, the HTx centers can only identify the parameters
      specific to their center. All other information will be reported anonymously.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 2012</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Self-reported non-adherence to immunosuppressive medication</measure>
    <time_frame>Once</time_frame>
    <description>Participants will be asked about immunosuppressive medication taking during the prior 4 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-reported non-adherence to other medications (excl. immunosuppressive medications)</measure>
    <time_frame>Once</time_frame>
    <description>Participants will be asked about adherence to other medications (excl. immunosuppressive medications) during the prior 4 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported adherence to smoking cessation</measure>
    <time_frame>Once</time_frame>
    <description>Participants will be asked about current and past smoking</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported adherence to dietary modifications</measure>
    <time_frame>once</time_frame>
    <description>Participants will be asked about adherence to dietary recommendations during the past year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported alcohol use</measure>
    <time_frame>Once</time_frame>
    <description>Participants are asked about alcohol intake during the past year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported adherence to physical activity</measure>
    <time_frame>Once</time_frame>
    <description>Participants are asked about their level of physical activity during the past week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported adherence to sun protection</measure>
    <time_frame>Once</time_frame>
    <description>Participants will be asked about the routine use of sun protection measures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported adherence to appointment keeping</measure>
    <time_frame>Once</time_frame>
    <description>Participants will be asked if they kept the last five appointments with the transplant team</description>
  </secondary_outcome>
  <enrollment type="Actual">1365</enrollment>
  <condition>Heart Transplantation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult heart transplant recipients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Heart transplant patients

          -  18 years or older at time of inclusion

          -  Transplanted and followed-up for routine care in a participating transplant center

          -  First transplant

          -  Single-organ transplant

          -  Between 1 and 5 years post-transplant

          -  Ability to read, understand and sign written informed consent (in Dutch, English,
             French, German, Spanish, Italian, or Portuguese, depending on the languages spoken
             within the country where the participating transplant center is located)

          -  Provided written informed consent

        Exclusion Criteria:

          -  Receiving professional support in medication taking

          -  Involved in adherence-intervention research or drug trials during the past 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sabina M De Geest, PhD, RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Basel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospitals of Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Berben L, Russell C, Engberg S, Dobbels F, De Geest S. Development, content validity and inter-rater reliability testing of the Chronic Illness Management Implementation - Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation: An instrument to assess the level of chronic illness management implemented in solid organ transplant programmes. International Journal of Care Coordination. 2014;17(1-2):59-71.</citation>
  </reference>
  <reference>
    <citation>Berben L, Denhaerynck K, Dobbels F, Engberg S, Vanhaecke J, Crespo-Leiro MG, Russell CL, De Geest S; BRIGHT study consortium. Building research initiative group: chronic illness management and adherence in transplantation (BRIGHT) study: study protocol. J Adv Nurs. 2015 Mar;71(3):642-54. doi: 10.1111/jan.12519. Epub 2014 Sep 26.</citation>
    <PMID>25257974</PMID>
  </reference>
  <results_reference>
    <citation>Cajita MI, Denhaerynck K, Dobbels F, Berben L, Russell CL, Davidson PM, De Geest S; BRIGHT study team. Health literacy in heart transplantation: Prevalence, correlates and associations with health behaviors-Findings from the international BRIGHT study. J Heart Lung Transplant. 2017 Mar;36(3):272-279. doi: 10.1016/j.healun.2016.08.024. Epub 2016 Sep 13.</citation>
    <PMID>27773449</PMID>
  </results_reference>
  <results_reference>
    <citation>Cajita MI, Baumgartner E, Berben L, Denhaerynck K, Helmy R, Schönfeld S, Berger G, Vetter C, Dobbels F, Russell CL, De Geest S; BRIGHT Study Team. Heart transplant centers with multidisciplinary team show a higher level of chronic illness management - Findings from the International BRIGHT Study. Heart Lung. 2017 Sep - Oct;46(5):351-356. doi: 10.1016/j.hrtlng.2017.05.006. Epub 2017 Jun 16.</citation>
    <PMID>28624338</PMID>
  </results_reference>
  <results_reference>
    <citation>Senft Y, Kirsch M, Denhaerynck K, Dobbels F, Helmy R, Russell CL, Berben L, De Geest S; BRIGHT study team. Practice patterns to improve pre and post-transplant medication adherence in heart transplant centres: a secondary data analysis of the international BRIGHT study. Eur J Cardiovasc Nurs. 2017 Dec 1:1474515117747577. doi: 10.1177/1474515117747577. [Epub ahead of print]</citation>
    <PMID>29231747</PMID>
  </results_reference>
  <results_reference>
    <citation>Denhaerynck K, Berben L, Dobbels F, Russell CL, Crespo-Leiro MG, Poncelet AJ, De Geest S; BRIGHT study team. Multilevel factors are associated with immunosuppressant nonadherence in heart transplant recipients: The international BRIGHT study. Am J Transplant. 2017 Dec 5. doi: 10.1111/ajt.14611. [Epub ahead of print]</citation>
    <PMID>29205855</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2012</study_first_submitted>
  <study_first_submitted_qc>May 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 31, 2012</study_first_posted>
  <last_update_submitted>January 12, 2018</last_update_submitted>
  <last_update_submitted_qc>January 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Basel</investigator_affiliation>
    <investigator_full_name>Sabina De Geest</investigator_full_name>
    <investigator_title>PhD, RN, FAAN, FRCN</investigator_title>
  </responsible_party>
  <keyword>Heart transplantation</keyword>
  <keyword>Medication adherence</keyword>
  <keyword>Behavior system factor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>Study Protocol</doc_type>
      <doc_url>http://dx.doi.org/10.1111/jan.12519</doc_url>
      <doc_comment>Building research initiative group: chronic illness management and adherence in transplantation (BRIGHT) study: study protocol</doc_comment>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

